Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cannabis Consumption Used by Cancer Patients during Immunotherapy Correlates with Poor Clinical Outcome
Gil Bar‐Sela, Idan Cohen, Salvatore Campisi‐Pinto, et al.
Cancers (2020) Vol. 12, Iss. 9, pp. 2447-2447
Open Access | Times Cited: 103

Showing 1-25 of 103 citing articles:

Cannabinoids as anticancer drugs: current status of preclinical research
Burkhard Hinz, Robert Ramer
British Journal of Cancer (2022) Vol. 127, Iss. 1, pp. 1-13
Open Access | Times Cited: 97
Cannabis and Cannabinoids in Adults With Cancer: ASCO Guideline
Ilana M. Braun, Kari Bohlke, Donald I. Abrams, et al.
Journal of Clinical Oncology (2024) Vol. 42, Iss. 13, pp. 1575-1593
Closed Access | Times Cited: 19
Cannabis, Cannabinoids and Cannabis-Based Medicines in Cancer Care
Donald I. Abrams
Integrative Cancer Therapies (2022) Vol. 21
Open Access | Times Cited: 39
Cannabis Use in Patients With Cancer: A Clinical Review
Brooke Worster, Emily Hajjar, Nathan Handley
JCO Oncology Practice (2022) Vol. 18, Iss. 11, pp. 743-749
Closed Access | Times Cited: 38
MASCC guideline: cannabis for cancer-related pain and risk of harms and adverse events
Josephine To, Mellar P. Davis, Andrea Sbrana, et al.
Supportive Care in Cancer (2023) Vol. 31, Iss. 4
Closed Access | Times Cited: 30
Integrative Therapies in Cancer Care: An Update on the Guidelines
Krisstina Gowin, Meri Muminovic, Suzanna M. Zick, et al.
American Society of Clinical Oncology Educational Book (2024) Vol. 44, Iss. 3
Closed Access | Times Cited: 12
Why and How to Integrate Early Palliative Care Into Cutting-Edge Personalized Cancer Care
Laura A. Petrillo, Katie Fitzgerald Jones, Areej El‐Jawahri, et al.
American Society of Clinical Oncology Educational Book (2024) Vol. 44, Iss. 3
Closed Access | Times Cited: 10
Impact of cannabinoids on cancer outcomes in patients receiving immune checkpoint inhibitor immunotherapy
MariaLuisa Vigano, Lixing Wang, Alia As’sadiq, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access | Times Cited: 1
“Is medical cannabis safe for my patients?” A practical review of cannabis safety considerations
Caroline A. MacCallum, Lindsay A. Lo, Michael Boivin
European Journal of Internal Medicine (2021) Vol. 89, pp. 10-18
Open Access | Times Cited: 52
A randomized trial of medical cannabis in patients with stage IV cancers to assess feasibility, dose requirements, impact on pain and opioid use, safety, and overall patient satisfaction
Dylan M. Zylla, Justin Eklund, Grace Gilmore, et al.
Supportive Care in Cancer (2021) Vol. 29, Iss. 12, pp. 7471-7478
Closed Access | Times Cited: 48
A Coala‐T‐Cannabis Survey Study of breast cancer patients' use of cannabis before, during, and after treatment
Marisa C. Weiss, Julianne Hibbs, Meghan Buckley, et al.
Cancer (2021) Vol. 128, Iss. 1, pp. 160-168
Open Access | Times Cited: 44
Cannabidiol and Other Phytocannabinoids as Cancer Therapeutics
Gerhard Nahler
Pharmaceutical Medicine (2022) Vol. 36, Iss. 2, pp. 99-129
Open Access | Times Cited: 33
Use of Cannabis and Cannabinoids for Treatment of Cancer
Viktoriia Cherkasova, Bo Wang, Marta Gerasymchuk, et al.
Cancers (2022) Vol. 14, Iss. 20, pp. 5142-5142
Open Access | Times Cited: 31
Tetrahydrocannabinol and cannabidiol medicines for chronic pain and mental health conditions
Jeremy D. Henson, Luis Vitetta, Sean Hall
Inflammopharmacology (2022) Vol. 30, Iss. 4, pp. 1167-1178
Open Access | Times Cited: 30
Beyond Pain Relief: A Review on Cannabidiol Potential in Medical Therapies
Mariana Veiga, João Azevedo‐Silva, João Carlos Fernandes
Pharmaceuticals (2023) Vol. 16, Iss. 2, pp. 155-155
Open Access | Times Cited: 17
Potential, Limitations and Risks of Cannabis-Derived Products in Cancer Treatment
Herman J. Woerdenbag, Peter Olinga, Ellen A. Kok, et al.
Cancers (2023) Vol. 15, Iss. 7, pp. 2119-2119
Open Access | Times Cited: 17
“The Two Sides of the Same Coin”—Medical Cannabis, Cannabinoids and Immunity: Pros and Cons Explained
Mona Khoury, Idan Cohen, Gil Bar‐Sela
Pharmaceutics (2022) Vol. 14, Iss. 2, pp. 389-389
Open Access | Times Cited: 27
Therapeutic targeting of the tumor microenvironments with cannabinoids and their analogs: Update on clinical trials
Sheik Aliya, Marzieh Ramezani Farani, Eunsu Kim, et al.
Environmental Research (2023) Vol. 231, pp. 115862-115862
Closed Access | Times Cited: 13
Medical cannabis for children: Evidence and recommendations
Lauren E. Kelly, Michael Rieder, Yaron Finkelstein
Paediatrics & Child Health (2024) Vol. 29, Iss. 2, pp. 104-112
Open Access | Times Cited: 5
Has medicinal cannabis found a role in oncology/palliative care?
Janet Hardy, Phillip Good
Internal Medicine Journal (2025)
Closed Access
The impact of cannabis on immune checkpoint inhibitor therapy: a systematic review of immunomodulatory effects of cannabis in patients with and without cancer
Caroline Behling-Hess, Grant Simonson, Talya Salz, et al.
Supportive Care in Cancer (2025) Vol. 33, Iss. 3
Closed Access
The Complexity of Malignant Glioma Treatment
Linde F. C. Kampers, Dennis S. Metselaar, Maria Vinci, et al.
Cancers (2025) Vol. 17, Iss. 5, pp. 879-879
Open Access
SITC strategic vision: prevention, premalignant immunity, host and environmental factors
Sasha E. Stanton, Kristin G. Anderson, Tullia C. Bruno, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 3, pp. e010419-e010419
Open Access
Research mapping of cannabinoids and endocannabinoid system in cancer over the past three decades: insights from bibliometric analysis
Yaqian Tan, Hui Xia, Qi Song
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Effects of cannabinoids on immune checkpoint inhibitor response: CCTG pooled analysis of individual patient data
Courtney H. Coschi, Keyue Ding, Justin Tong, et al.
Immunotherapy (2025), pp. 1-12
Closed Access
Page 1 - Next Page

Scroll to top